Ideeea Therapeutics Selected Among the TOP15 Startups Transforming Spanish Biotechnology

We are pleased to announce that Ideeea Therapeutics has been recognized by Diario El Referente as one of the 15 startups that are redefining the biotech landscape in Spain.

This recognition highlights our contribution to the advancement of advanced therapies (ATMPs) through an innovative, rigorous, and patient-centered approach.

Leading Innovation in Regenerative Dermatology

From Spain, Ideeea Therapeutics researches and develops cutting-edge biotechnological solutions in regenerative dermatology. Our AGAcell® program, focused on the treatment of androgenetic alopecia, continues to advance with the potential to extend to other skin conditions where regenerative medicine can make a meaningful difference.

A Model Based on Open Innovation and Collaboration

We strongly believe in an open innovation model, working closely with hospitals, clinical teams, universities, and strategic partners. This collaborative network enables us to bring advanced biotechnology closer to clinical practice, ensuring scientific excellence, safety, and real-world applicability for patients.

A Recognition That Strengthens Our Vision

Being part of the TOP15 reinforces our mission:
to develop high-impact therapeutic solutions that improve patient health, combining scientific robustness, regulatory rigor, and long-term strategic alliances.

At Ideeea Therapeutics, we remain committed to driving a new generation of advanced therapies that will transform the future of regenerative dermatology.